Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi

Gilead Sciences Inc. scored victories on the regulatory and legal fronts, sending its stock higher. An arbitration panel ruled Friday that the Foster City-based drug maker’s hepatitis C blockbuster Sovaldi did not infringe a 2004 research deal that rival Roche had with Pharmasset Inc...